← Insider buys
SYRS

Syros Pharmaceuticals, Inc. · Healthcare

CFO Jason Haas sold $29K of Syros Pharmaceuticals, Inc.

Sold$28,980
$0.21Price
137,803Shares
−100%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Mon, Nov 18. Filed Wed, Nov 20, 5:00 PM ET, after the close. Not investment advice.